Walgreens Boots Alliance (NASDAQ: WBA) reported fourth-quarter 2020 financial results before the opening bell on Thursday. The retail pharma giant reported a 2% rise in Q4 sales to $34.7 billion, beating the Wall Street consensus. Earnings of $1.02 per share were also stronger than what analysts had anticipated.
WBA shares gained 2.4% immediately following the announcement. The stock has slipped 39% since the beginning of this year.
CEO Stefano Pessina said, “Now, more than ever, our pharmacy-centered business is at the heart of community healthcare and we are expanding on that role for the future. I continue to be inspired by the tireless efforts of our teams as they support and care for our customers, patients and communities, while accelerating progress on our clear set of strategic priorities.”
Prior performance
Most Popular
PEP Earnings: All you need to know about PepsiCo’s Q3 2024 earnings results
PepsiCo, Inc. (NASDAQ: PEP) reported its third quarter 2024 earnings results today. Net revenue dipped 0.6% to $23.3 billion compared to the same period a year ago. Organic revenue growth
Walgreens Boots Alliance’s Q4 results likely to reflect market challenges
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been struggling to maintain sales momentum and profitability for quite some time due to a challenging operating environment. The main headwinds to the
Bank earnings preview: What to expect when the banking giants report Q3 2024 results
A slew of major banks are set to report their earnings results for the third quarter of 2024 over this week and the next. The focus will be on interest
